Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Open-label Clinical Trial to Assess Fever Following Simultaneous Versus Sequential Administration of PCV13, DTaP Vaccine and IIV in Young Children

NCT03165981 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03165981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03165981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Open-label Clinical Trial to Assess Fever Following Simultaneous Versus Sequential Administration of PCV13, DTaP Vaccine and IIV in Young Children
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Completed
Start date
August 25, 2017
Completion date
January 15, 2018
Enrollment
221 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

febrile seizure, fever, fever after vaccination